OpenVSafe by OpenVAERS
Search V-safe

GKR-22804-59126

3 vaccinations 2 coded responses 31 check-ins 2 free-text entries 1 call case
Sex
Female
Age at first dose
41-45
ZIP prefix
392 / MS
Registered
2021-03-06
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-06
    Registered in v-safe
  2. 2021-03-06
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-06
    Health check-in — day 0, dose 1
    Feeling: Fair · None
    Adult check-in
  4. 2021-03-07
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-08
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  6. 2021-03-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  7. 2021-03-10
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  8. 2021-03-11
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  9. 2021-03-12
    Survey response — days 1–6 daily, dose 1
    MedDRA: Muscle tightness, Tenderness — Feeling: Fair · Site: Swelling
    Free text: Neck tenderness
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-03-13
    Health check-in — day 7, dose 1
    Feeling: Fair · None
    Adult check-in
  11. 2021-03-20
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-27
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  13. 2021-03-31
    Dose 2 — Pfizer-BioNTech
  14. 2021-03-31
    Health check-in — day 0, dose 2
    Feeling: Fair · None
    Adult check-in
  15. 2021-04-01
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Swelling · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  16. 2021-04-02
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain, Redness, Swelling · Fever · Chills, Fatigue or tiredness
    Adult check-in
  17. 2021-04-03
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Redness, Swelling · None
    Adult check-in
  18. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  19. 2021-04-05
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  20. 2021-04-06
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  21. 2021-04-07
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  22. 2021-04-14
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-21
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-04-28
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-05
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-05-12
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-06-30
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-01
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  29. 2021-12-03
    Dose 3 — Pfizer-BioNTech
  30. 2022-01-03
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  31. 2022-01-07
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  32. 2022-01-14
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  33. 2022-03-04
    Health check-in — 3 months, dose 3
    Feeling: Good
    Adult check-in
  34. 2022-06-03
    Survey response — 6 months, dose 3
    MedDRA: Pregnancy, Thrombosis, Uterine dilation and curettage — Feeling: Fair · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit, Emergency room or emergency department visit, Hospitalization
    Free text: Symptoms: Blood clots in legs and uterus along with pregnancy · Healthcare visit (other): D and C
    MedDRA releases: 2024-11 · check-in free text available
  35. 2022-06-03
    Report sent to call center — 6 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  36. 2022-06-07
  37. 2022-06-10
  38. 2022-12-04
    Health check-in — 12 months, dose 3
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-06Pfizer-BioNTech
22021-03-31Pfizer-BioNTech
32021-12-03Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-06-03 Unsuccessful

Free text

Release 5 — days 1–6 daily, dose 1

2021-03-12

Systemic reaction (other): Neck tenderness

Release 11 — 6 months, dose 3

2022-06-03

Symptoms: Blood clots in legs and uterus along with pregnancy
Healthcare visit (other): D and C

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOUterine dilation and curettage · · ✓
SDPregnancy · · ✓
SDThrombosis · · ✓
SROMuscle tightness ✓ ✓ ○
SROTenderness · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…